IRB Study Number 22-547
Status Recruiting
Location Cleveland Clinic Main Campus
Institute Respiratory Institute
Description
In this study, the investigators aim to evaluate changes in lung function in women with cystic fibrosis (CF) during pregnancy and for 2 years after pregnancy based on exposure to highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators.
Inclusion Criteria
Pregnant, intending to continue pregnancy, enrolled in the CFF registry
Exclusion Criteria
None
